Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors

Hwan Mook Kim, Sung Hee Hong, Myung Sook Kim, Chang Woo Lee, Jong Soon Kang, Kiho Lee, Song Kyu Park, Jeung Whan Han, Hee Yoon Lee, Yongseok Choi, Ho Jeung Kwon, Gyoonhee Han

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Novel δ-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities.

Original languageEnglish
Pages (from-to)6234-6238
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number22
DOIs
Publication statusPublished - 2007 Nov 15

Fingerprint

Lactams
Histone Deacetylase Inhibitors
Histone Deacetylases
Tumor Cell Line
Tumors
Structure-Activity Relationship
Growth
Cells
Heterografts
Neoplasms
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Kim, Hwan Mook ; Hong, Sung Hee ; Kim, Myung Sook ; Lee, Chang Woo ; Kang, Jong Soon ; Lee, Kiho ; Park, Song Kyu ; Han, Jeung Whan ; Lee, Hee Yoon ; Choi, Yongseok ; Kwon, Ho Jeung ; Han, Gyoonhee. / Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors. In: Bioorganic and Medicinal Chemistry Letters. 2007 ; Vol. 17, No. 22. pp. 6234-6238.
@article{2c02880da77941f28dbdf80ba6047be3,
title = "Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors",
abstract = "Novel δ-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities.",
author = "Kim, {Hwan Mook} and Hong, {Sung Hee} and Kim, {Myung Sook} and Lee, {Chang Woo} and Kang, {Jong Soon} and Kiho Lee and Park, {Song Kyu} and Han, {Jeung Whan} and Lee, {Hee Yoon} and Yongseok Choi and Kwon, {Ho Jeung} and Gyoonhee Han",
year = "2007",
month = "11",
day = "15",
doi = "10.1016/j.bmcl.2007.09.034",
language = "English",
volume = "17",
pages = "6234--6238",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "22",

}

Kim, HM, Hong, SH, Kim, MS, Lee, CW, Kang, JS, Lee, K, Park, SK, Han, JW, Lee, HY, Choi, Y, Kwon, HJ & Han, G 2007, 'Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors', Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 22, pp. 6234-6238. https://doi.org/10.1016/j.bmcl.2007.09.034

Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors. / Kim, Hwan Mook; Hong, Sung Hee; Kim, Myung Sook; Lee, Chang Woo; Kang, Jong Soon; Lee, Kiho; Park, Song Kyu; Han, Jeung Whan; Lee, Hee Yoon; Choi, Yongseok; Kwon, Ho Jeung; Han, Gyoonhee.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 17, No. 22, 15.11.2007, p. 6234-6238.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Modification of cap group in δ-lactam-based histone deacetylase (HDAC) inhibitors

AU - Kim, Hwan Mook

AU - Hong, Sung Hee

AU - Kim, Myung Sook

AU - Lee, Chang Woo

AU - Kang, Jong Soon

AU - Lee, Kiho

AU - Park, Song Kyu

AU - Han, Jeung Whan

AU - Lee, Hee Yoon

AU - Choi, Yongseok

AU - Kwon, Ho Jeung

AU - Han, Gyoonhee

PY - 2007/11/15

Y1 - 2007/11/15

N2 - Novel δ-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities.

AB - Novel δ-lactam-based HDAC inhibitors which have various substituted benzyl, bi-aromatic cap groups were prepared using ring closure metathesis reaction, and evaluated their HDAC inhibitory activities and anti-proliferative effects. Among prepared analogues, 11m and 11o have very strong HDAC enzymatic inhibition and showed the most potent growth inhibitory activity to five human tumor cell lines including PC-3, ACHN, NUGC-3, HCT-15, and MBA-MB-231 tumor cell lines. Compounds 11m and 11o also showed good tumor growth inhibition of MDA-MB-231 cells in in vivo xenograft model. Structure-activity relationship study using docking model explained the significance of hydrophobic aromatic cap groups for their in vitro activities.

UR - http://www.scopus.com/inward/record.url?scp=35148888600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35148888600&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2007.09.034

DO - 10.1016/j.bmcl.2007.09.034

M3 - Article

C2 - 17904843

AN - SCOPUS:35148888600

VL - 17

SP - 6234

EP - 6238

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 22

ER -